Current Strategies to Enhance Anti-Tumour Immunity.
作者： Katherine Cook , Lindy Durrant , Victoria Brentville
DOI: 10.3390/BIOMEDICINES6020037
关键词:
摘要: The interaction of the immune system with cancer is complex, but new approaches are resulting in exciting therapeutic benefits. In order to enhance response cancer, therapies seek either induce high avidity responses tumour specific antigens or convert a more pro-inflammatory microenvironment. Strategies, including vaccination, oncolytic viruses, and adoptive cell transfer all anti-tumour immunity. To overcome suppressive microenvironment checkpoint inhibitors modulators regulatory populations have been investigated. This review summarizes recent advances discusses importance combination treatment cancers.
mdpi.com
sci-hub.se 参考文章(167)
Bruno Pitard, Supramolecular assemblies of DNA delivery systems. Somatic Cell and Molecular Genetics. ,vol. 27, pp. 5- 15 ,(2002) , 10.1023/A:1022923721335
Katherine H. Parker, Daniel W. Beury, Suzanne Ostrand-Rosenberg, Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. Advances in Cancer Research. ,vol. 128, pp. 95- 139 ,(2015) , 10.1016/BS.ACR.2015.04.002
Karen Robinson, Jonathan White, Jody Winter, Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes Journal of Inflammation Research. ,vol. 8, pp. 137- 147 ,(2015) , 10.2147/JIR.S64888
F. M. Burnet, The concept of immunological surveillance. Progress in Experimental Tumor Research. ,vol. 13, pp. 1- 27 ,(1970) , 10.1159/000386035
Martijn S. Bijker, Susan J. F. van den Eeden, Kees L. Franken, Cornelis J. M. Melief, Rienk Offringa, Sjoerd H. van der Burg, CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund’s Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity Journal of Immunology. ,vol. 179, pp. 5033- 5040 ,(2007) , 10.4049/JIMMUNOL.179.8.5033
Peter P. Lee, Cassian Yee, Peter A. Savage, Lawrence Fong, Dirk Brockstedt, Jeffrey S. Weber, Denise Johnson, Susan Swetter, John Thompson, Philip D. Greenberg, Mario Roederer, Mark M. Davis, Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nature Medicine. ,vol. 5, pp. 677- 685 ,(1999) , 10.1038/9525
Amit A. Lugade, James P. Moran, Scott A. Gerber, Robert C. Rose, John G. Frelinger, Edith M. Lord, Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor Journal of Immunology. ,vol. 174, pp. 7516- 7523 ,(2005) , 10.4049/JIMMUNOL.174.12.7516
Soranobu Ninomiya, Neeharika Narala, Leslie Huye, Shigeki Yagyu, Barbara Savoldo, Gianpietro Dotti, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney, Carlos A. Ramos, Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs Blood. ,vol. 125, pp. 3905- 3916 ,(2015) , 10.1182/BLOOD-2015-01-621474
Yoshihiro Yoshitake, Yasuharu Nishimura, Yusuke Nakamura, Masanori Shinohara, A clinical trial of multiple peptides vaccination for advanced head and neck cancer patients induced immune responses and prolonged OS. OncoImmunology. ,vol. 4, ,(2015) , 10.1080/2162402X.2015.1022307
Bastian Schilling, Antje Sucker, Klaus Griewank, Fang Zhao, Benjamin Weide, André Görgens, Bernd Giebel, Dirk Schadendorf, Annette Paschen, Vemurafenib reverses immunosuppression by myeloid derived suppressor cells. International Journal of Cancer. ,vol. 133, pp. 1653- 1663 ,(2013) , 10.1002/IJC.28168